news aktuell GmbH

Compax MVNE continues to support Airalo’s eSIM platform

2.3.2026 14:46:10 CET | news aktuell GmbH | Press release

Share

Compax, a leading solution provider in the MVNO and telco space, will continue to support Airalo, the world’s first and largest eSIM platform.

(Vienna, Austria) Airalo and Compax have extended their partnership for another five years, ensuring Airalo continues to run on the powerful Compax backend platform. This technology allows Airalo to quickly launch and manage data plans across more than 200 destinations. By using the Compax real-time charging system, Airalo can accurately track data usage and set custom pricing independently, without having to rely on the technical systems of local phone carriers. This total control ensures that Airalo can offer its 20 million users the most flexible and competitive travel eSIM rates on the market.

Compax is proud to support Airalo as it continues to launch new products and services, ensuring its 20M+ customers can stay connected seamlessly across more than 200 destinations, regardless of their travel plans.

"At Airalo, our goal is to provide our customers with reliable connectivity and a seamless experience. Extending our partnership with Compax MVNE for another five years ensures we have the technical foundation to keep that promise,” explained Peter Nussbaumer, VP of Networks at Airalo. "Compax MVNE's platform gives us the independence to launch new products and manage complex global data plans in real-time, allowing us to stay agile and focus on what matters most: keeping our 20 million users connected, no matter where their journey takes them."

”The Airalo team set out to transform the way travelers enjoy connectivity abroad forever and they are not falling short on their goal. It’s an absolute pleasure for us to be a part of their journey and assist them on their mission. Connectivity is at the heart of everything we do in our modern ways of life and the Airalo offering is perfectly tuned to that beat.” said Werner Kohl, CEO of Compax.

Contacts

About Airalo

Airalo, founded in 2019, is the world’s largest travel eSIM platform. Trusted by over 20 million travelers, Airalo offers eSIM packages in 200+ destinations, empowering users to connect to mobile networks worldwide instantly. With a remote team of over 300 people, spanning more than 50 countries, Airalo is committed to making mobile connectivity on the move easier, more affordable, and accessible to all.

About Compax

Compax is a leading BSS/OSS software provider for the telecommunications industry. Its business software suite covers the full spectrum required to cover areas such as DSL, FTTH, MVNO and related industries: Apps and portals for customer orders and selfcare, convergent product catalog, CPQ, order management, CRM, contact center, billing, accounting, payments, online charging, and retail management. Compax enables operators to bring new services, offers, and brands to market with a quick turnaround and covering B2B, B2C, and B2B2X scenarios. Relying on proven agile methodology, Compax successfully serves top brands around the globe.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Grünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands2.3.2026 10:39:09 CET | Press release

Grünenthal acquired Kyowa Kirin International’s 49% stake in ‘Grünenthal Meds’, a joint venture formed in 2023 to market the established medicines portfolio from Kyowa Kirin International. Through this acquisition, Grünenthal assumes the sole responsibility of a portfolio comprising 12 brands across six therapeutic areas and >60 markets.

Vyoma awarded ESA data procurement contract for space-based data on small space debris24.2.2026 10:53:34 CET | Press release

(Munich, February 24th, 2026) Vyoma, a Munich-based company providing Space Domain Awareness (SDA) capabilities, has been selected as the winner of the ESA tender on ”Data Procurement for Space-Based Statistical Data on Small Space Debris Phase 1”, funded via ESA‘s Space Safety Programme (S2P). ESA’s Meteoroid And Space debris Terrestrial Environment Reference (MASTER) model provides a description of the space environment around Earth, supporting satellite designers, operators and others with risk assessments. Currently, there exists a significant temporal and spatial knowledge gap for observations of space debris with sizes smaller than the detection limit of ground-based sensors. Vyoma's Flamingo-1 satellite is ideally positioned to generate the image data ESA is seeking. Flying “in-situ” at an altitude of 510 km, Flamingo-1's instrument can monitor large volumes of space at once. This sensor detects objects at long and short distances and captures small and fast objects reliably, im

Medi-Globe Launches mAI Companion® — the World’s First Real Time AI Assistant for Pancreatic EUS, Co Developed with IHU Strasbourg —Now MDR CE Marked and Available for Clinical Use in Europe24.2.2026 10:00:00 CET | Press release

Rohrdorf (Achenmühle), Germany — February 24, 2026 — Medi-Globe today announced the launch of mAI Companion®, a real-time medical AI solution designed to assist physicians in detecting pancreatic lesions during endoscopic ultrasound (EUS) — addressing one of the deadliest and most difficult-to-detect cancers, where earlier identification can dramatically change patient outcomes.

Grünenthal licenses exclusive Australian rights to Qutenza® to Clinect24.2.2026 08:43:52 CET | Press release

Aachen, Germany & Victoria, Australia, 24 February 2026 – Grünenthal, a global leader in pain management and related diseases, and Clinect Pty Ltd ("Clinect"), an Australian based company focussed on supporting access to unique products, announced today that they have entered into a definitive agreement whereby Clinect will have the exclusive Australian rights to Qutenza®, a topical, non-systemic, non-opioid patch indicated for the management of peripheral neuropathic pain. Under the agreement, Clinect will be responsible for obtaining marketing authorisation for Qutenza® in Australia and, upon approval, marketing and distributing the product in Australia.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye